Skip to: Content
Skip to: Site Navigation
Skip to: Search

December 2, 2008 6:14:08 AM CST

Learn about Newser Points »

« Back to the grid | Next story »

Merck Used Ghostwriters to Draft Rosy Vioxx Studies

Posted Apr 15, 08 7:51 PM CDT in Business,  Science & Health 

(Newser) – Merck used its own ghostwriters to draft articles minimizing risks of its drug Vioxx, then found medical researchers to lend their names to the research, the Wall Street Journal reports. Merck, which pulled the painkiller from shelves four years ago over heart-attack risks, rejects the claims as "misleading." They appear in tomorrow's edition of the Journal of the American Medical Association.

“It almost calls into question all legitimate research that’s been conducted by the pharmaceutical industry with the academic physician,” the lead researcher of the JAMA study tells the New York Times. He says the ghostwriting practice is widespread in the industry, and a companion editorial in JAMA calls for immediate changes.

Sources Wall Street Journal, New York Times

0 comments | Print E-mail | Digg Seed this on Newsvine Add this link to Del.icio.us StumbleUpon

Related Newser Stories

  • Merck Will Pay $650M to End Discount Probes

    Feb 7, 08 3:59 PM CST
    Merck Will Pay $650M to End Discount Probes Drug company Merck will dish out $650 million to resolve lawsuits and probes into marketing schemes, the Wall Street Journal reports. Central to the investigations is the company’s “nominal pricing,” which slashed some drug prices by 90% for hospitals but hid the discounts from Medicaid, even though federal law demands that drug companies offer the government program their lowest prices. More »

Vioxx is arranged on a counting tray in this 2004 file photo.   (AP Photo/Daniel Hulshizer, File)
This handout image shows the logo for Merck & Co.   (Getty Images (by Event))
« Prev« Prev | Next »Next » Slideshow
Our editors also recommend:

Threads (
1
 of 3)

Tags

ethics • pharmaceutical companies • Merck • medical study • Vioxx • JAMA


Loading...

Premium Articles from HighBeam

Find more articles like this

Today's Most Popular

Loading...

Other Science & Health Stories

What is Newser?

2008 Codie Finalist

Face it: there's too much news. At Newser a team of editors and writers culls the most important stories from hundreds of U.S. and international sources and reduces them to a headline, picture, and two paragraphs. It's the Newser guarantee: we can take any report or column or video and pack what you need to know into 120 words or less. Newser's short-form aggregation, visual format, and unique information tools help you get more of the kind of news you want, in a quicker and more entertaining way. And we do it 24/7—you can come back morning, noon, night (and in between) for something new that matters. Read less, know more.

Learn more »